Elevated circulating levels of von Willebrand factor and D-DIMER in patients with heart failure and mechanical prosthesis

Scandinavian Journal of Thoracic and Cardiovascular Surgery

Volumn 30, Issue 2, 1996, Pages 77-81

  Mastroroberto, Pasquale ^a   Chello, Massimo ^a   Perticone, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Coagulation; Heart failure; Thromboembolism; Valve prosthesis; Von Willebrand factor

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; COUMARIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THROMBOCYTE ACTIVATING FACTOR; VON WILLEBRAND FACTOR; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; HYPOTHESIS; MITRAL VALVE PROSTHESIS; PRIORITY JOURNAL; PULMONARY ARTERY; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM;

EID: 0030035573     PISSN: 00365580     EISSN: None     Source Type: Journal    
DOI: 10.3109/14017439609107246     Document Type: Article

References (15)

1. Angles-Cano E, Sultan Y, Clauvel JP. Predisposing factors to thrombosis in systemic lupus erythematosus. J Lab clin Med 1979; 94: 313-323.
2. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992; 85: 504-509.
3. Grandel KE, Fan RS, Wanderer AA, Einsenstadt TC, Wasserman SI. Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 1985; 313: 405-409.
4. Gough SC, Prentice CR. The investigation of a heart valve patient with suspected hypercoagulability. J Heart Valve Dis 1993; 2: 1-6.
5. Greaves M, Pickering C, Knight G. Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? Diabetologia 1987; 30: 160-165.
6. Jansson J-H, Nilsson TK, Olofsson B-O. On the predictive value of plasminogen activator assays in patients with angiographically verified coronary artery disease. Eur Heart J 1991; 12: 157-161.
7. Jansson J-H, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-355.
8. Ohar JA, Pyle JA, Hyers TM, Webster RO. AGEPC-induced pulmonary vascular injury - a rabbit model of pulmonary hypertension. Am Rev Respir Dis 1986; 133: 159A.
9. Penny WF, Weinstein M, Salzman EW, Ware AJ. Correlation of circulating von Willebrand factor with cardiovascular hemodynamics. Circulation 1991; 83: 1630-1636.
10. Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley CM, Cleland JGF. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J 1994; 127: 607-612.
11. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-1518.
12. Turner-Gomes SO, Andrew M, Coles J, Trusler GA, Williams WG, Rabinovitch M. Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. J Thorac Cardiovasc Surg 1992; 103: 87-97.
13. Wahlberg T, Blomback M, Overmark I. Blood coagulation studies in 45 patients with ischaemic cerebrovascular disease and 44 patients with venous thromboembolic disease. Acta Med Scand 1980; 207: 385-390.
14. Weiss HJ, Hover LW, Rickles FR, Varman A, Rogers J. Quantitative assay of plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation: relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 1973; 52: 2708-2716.
15. Zimmerman TS, Hoyer LW, Dickson L, Edgington TS. Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med 86 1975; 86: 152-159.